Genetic studies in chronic kidney disease: Basic concepts

Journal of Nephrology

Volumn 25, Issue 2, 2012, Pages 141-149

  Nordfors, Louise ^a,b   Luttropp, Karin ^a,b   Carrero, Juan Jesus ^a,b   Witasp, Anna ^b   Stenvinkel, Peter ^b   Lindholm, Bengt ^b   Schalling, Martin ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Complex renal diseases; Genetics; Genome wide association studies; Kidney disease; Polymorphisms; Study strategies

Indexed keywords

MESSENGER RNA;

ACE GENE; ARTICLE; BINDING SITE; CCR5 GENE; CHRONIC KIDNEY DISEASE; COPY NUMBER VARIATION; CRP GENE; DNA SEQUENCE; DNA TRANSCRIPTION; ENVIRONMENTAL IMPACT; EPIGENETICS; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENE PRODUCT; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KIDNEY FAILURE; MPO GENE; MTHFR GENE; POPULATION GENETICS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

CHRONIC DISEASE; GENETICS, POPULATION; GENOME, HUMAN; HUMANS; KIDNEY DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863311137     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000145     Document Type: Article

References (46)

1. Lander ES, Linton LM, Birren B, et al; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860-921.
2. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291(5507):1304-1351.
3. McKnight AJ, Currie D, Maxwell AP. Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders. J Pathol. 2010;220(2):198-216.
4. National Center for Biotechnology Information. NCBI: db-SNP short genetic variations. Available at: http://www.ncbi. nlm.nih.gov/projects/SNP/. Accessed Feb 13, 2012.
5. Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int. 2005;67(6):2383-2392.
6. Nakayama Y, Nonoguchi H, Kohda Y, et al. Different mechanisms for the progression of CKD with ACE gene polymorphisms. Nephron Clin Pract. 2009;111(4):c240-c246.
7. Elshamaa MF, Sabry SM, Bazaraa HM, et al. Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease. J Inflamm (Lond). 2011;8(1):20.
8. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med. 2010;61(1):437-455.
9. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004; 305(5683):525-528.
10. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36(9):949-951.
11. Cappuzzo F, Hirsch FR, Rossi E, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in nonsmall-cell lung cancer. J Natl Cancer Inst. 2005;97(9):643-655.
12. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/ AIDS susceptibility. Science. 2005;307(5714):1434-1440.
13. Aitman TJ, Dong R, Vyse TJ, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature. 2006;439(7078):851-855.
14. Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O, Johansen KL. Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int. 2005;68(1):278-284.
15. Vasudevan R, Norhasniza MN, Patimah I. Association of variable number of tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in Malaysian patients. Genet Mol Res. 2011;10(2):943-947.
16. Elshamaa MF, Sabry S, Badr A, et al. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease. Blood Coagul Fibrinolysis. 2011;22(6):487-492.
17. Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation: a novel risk factor for cardiovascular disease? J Intern Med. 2007;261(5):488-499.
18. Feinberg AP. Epigenetics at the epicenter of modern medicine. JAMA. 2008;299(11):1345-1350.
19. Strom TM, Wienker TF. DeFinetti program. Available at: http:// ihg.gsf.de/cgi-bin/hw/hwa1.pl. Accessed Feb 22, 2012.
20. Kocsis I, Györffy B, Németh E, Vásárhelyi B. Examination of Hardy-Weinberg equilibrium in papers of Kidney International: an underused tool. Kidney Int. 2004;65(5):1956-1958.
21. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659-663.
22. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002; 296(5576):2225-2229.
23. Pritchard JK, Przeworski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet. 2001;69(1):1-14.
24. Frisse L, Hudson RR, Bartoszewicz A, Wall JD, Donfack J, Di Rienzo A. Gene conversion and different population histories may explain the contrast between polymorphism and linkage disequilibrium levels. Am J Hum Genet. 2001;69(4):831-843.
25. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet. 2001;29(2):233-237.
26. Online Mendelian Inheritance in Man [online database]. Johns Hopkins University. Available at: http://www.omim. org/. Accessed Feb 22, 2012.
27. Leitch CC, Zaghloul NA, Davis EE, et al. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat Genet. 2008;40(4):443-448.
28. Hildebrandt F. Genetic kidney diseases. Lancet. 2010;375 (9722):1287-1295.
29. ERA-EDTA Working Group on Inherited Kidney Disorders. WGiKD. Available at: http://www.era-edta.org/wgikd/ERAEDTA_ working_group_on_Inherited_kidney_disorders.htm. Accessed Feb 22, 2012.
30. Muntinghe FL, Verduijn M, Zuurman MW, et al. CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol. 2009;20(7):1641-1649.
31. Muntinghe FL, Vegter S, Verduijn M, et al. Using a genetic, observational study as a strategy to estimate the potential costeffectiveness of pharmacological CCR5 blockade in dialysis patients. Pharmacogenet Genomics. 2011;21(7):417-425.
32. Chambers JC, Zhang W, Lord GM, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010;42(5):373-375.
33. Ehret GB, Munroe PB, Rice KM, et al; International Consortium for Blood Pressure Genome-Wide Association Studies; CARDIoGRAM consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen consortium; CHARGE-HF consortium. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103-109.
34. Wiki Contributors. Exome chip design. Available at: http://genome. sph.umich.edu/wiki/Exome_Chip_Design. Accessed Feb 22, 2012.
35. Metzker ML. Sequencing technologies: the next generation. Nat Rev Genet. 2010;11(1):31-46.
36. Casals F, Idaghdour Y, Hussin J, Awadalla P. Next-generation sequencing approaches for genetic mapping of complex diseases. J Neuroimmunol. 2012 Jan 26. [Epub ahead of print].
37. Online Mendelian Inheritance in Man. OMIM database statistics. Available at: http://omim.org/statistics/geneMap. Accessed Feb 22, 2012.
38. Ovunc B, Otto EA, Vega-Warner V, et al. Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria. J Am Soc Nephrol. 2011;22(10):1815-1820.
39. Human Genome Epidemiology Network. HuGENet database. Available at: http://www.cdc.gov/genomics/hugenet/ default.htm. Accessed Feb 13, 2012.
40. Little J, Higgins JP, Ioannidis JP, et al; STrengthening the REporting of Genetic Association Studies. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009;6(2):e22.
41. Zoccali C, Testa A, Spoto B, Tripepi G, Mallamaci F. Mendelian randomization: a new approach to studying epidemiology in ESRD. Am J Kidney Dis. 2006;47(2):332-341.
42. Verduijn M, Prein RA, Stenvinkel P, et al. Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach. Nephrol Dial Transplant. 2011;26(1):239-245.
43. Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant. 2010;25(5):1394-1398.
44. Chmielewski M, Verduijn M, Drechsler C, et al. Low cholesterol in dialysis patients: causal factor for mortality or an effect of confounding? Nephrol Dial Transplant. 2011;26(10):3325-3331.
45. Renal Genome Network project. Available at: www.regenet. eu/. Accessed Feb 22, 2012.
46. Brenchley PE, Lindholm B, Dekker FW, Navis G. Translating knowledge of the human genome into clinical practice in nephrology dialysis and transplantation: the renal genome network (ReGeNet). Nephrol Dial Transplant. 2006;21(10):2681-2683.